Search in:

Expert Review of Vaccines Volume 19, 2020 - Issue 4

Submit an article Journal homepage

Open access

3,600

Views

CrossRef citations to date

Altmetric

Review

Immune surveillance for vaccine-preventable diseases

Gerco den HartogCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The NetherlandsCorrespondence[email protected]

https://orcid.org/0000-0002-2103-6315 View further author information

Rob van BinnendijkCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands

https://orcid.org/0000-0002-5808-1443 View further author information

Anne-Marie BuismanCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands

https://orcid.org/0000-0001-5085-7844 View further author information

Guy A. M. BerbersCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands

https://orcid.org/0000-0002-0390-1803 View further author information

Fiona R. M. van der KlisCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands

https://orcid.org/0000-0002-6759-3539 View further author information

Pages 327-339 | Received 06 Dec 2019, Accepted 17 Mar 2020, Published online: 29 Mar 2020

Cite this article
https://doi.org/10.1080/14760584.2020.1745071
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (11)

Yannick van Sleen, Kornelis S. M. van der Geest, Anne‐Marie Buisman, Maria Sandovici, Debbie van Baarle & Elisabeth Brouwer. (2023) Humoral SARS – CoV ‐2 Vaccine Responses in Patients With Giant Cell Arteritis and Polymyalgia Rheumatica: Decay After Primary Vaccination and Effects of the Booster . Arthritis Care & Research.
Crossref

Adi V Gundlapalli, Susan E Beekmann, Jefferson M Jones, Natalie J Thornburg, Kristie E N Clarke, Timothy M Uyeki, Panayampalli S Satheshkumar, Darin S Carroll, Ian D Plumb, Melissa Briggs-Hagen, Scott Santibañez, Corinne David-Ferdon, Philip M Polgreen & L Clifford McDonald. (2023) Use of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Tests by US Infectious Disease Physicians: Results of an Emerging Infections Network Survey, March 2022. Open Forum Infectious Diseases 10:3.
Crossref

Arthur H. van Stigt, Katrien Oude Rengerink, Kitty W. M. Bloemenkamp, Wouter de Waal, Sabine M. P. J. Prevaes, Thuy-My Le, Femke van Wijk, Maaike Nederend, Anneke H. Hellinga, Christianne S. Lammers, Gerco den Hartog, Martijn J. C. van Herwijnen, Johan Garssen, Léon M. J. Knippels, Lilly M. Verhagen, Caroline G. M. de Theije, Alejandro Lopez-Rincon, Jeanette H. W. Leusen, Belinda van’t Land, Louis Bont, André C. Knulst, C. Kors van der Ent, Debbie van Baarle, Marca H. M. Wauben, Nynke Y. Rots, Elisabeth A. M. Sanders, Manon J. N. L. Benders, Laura A. M. P. Meulenbroek, Bernd Stahl, Aletta D. Kraneveld, Brigitte J. M. Buiteman, Tanja Voogt, Barbara van der Meij, Butsabong Lerkvaleekul, Eline Voogd, Christianne S. Lammers, Tariq A. Lalmahomed, Iris M. Brus, Daphne M. M. van Meerwijk & Sophie I. E. Jepma. (2022) Analysing the protection from respiratory tract infections and allergic diseases early in life by human milk components: the PRIMA birth cohort. BMC Infectious Diseases 22:1.
Crossref

I. V. Konovalov, A. V. Zholinsky, S. P. Alpatov, A. V. Zorenko, N. V. Tochtieva, B. K. Romanov & S. A. Parastaev. (2022) Vaccination as an immune system status optimization tool for the high-performance sports: review. Sports medicine: research and practice 12:2, pages 73-81.
Crossref

Engy Mohamed El-Ghitany, Ayat Ashour, Marwa M. Fekry, Ehab Elrewany, Azza Galal Farghaly & Eman A. Omran. (2022) Seroprevalence of Hepatitis A, B and C Among a Sample of Refugees in Egypt: An Exploratory Survey. Journal of Epidemiology and Global Health 12:4, pages 430-440.
Crossref

Georg Bauer. (2022) High avidity of vaccine-induced immunoglobulin G against SARS-CoV-2: potential relevance for protective humoral immunity. Exploration of Immunology, pages 133-156.
Crossref

N. Amini, M. Mann, C. Hempton, T. King & J. Loy. 2022. The Science behind the COVID Pandemic and Healthcare Technology Solutions. The Science behind the COVID Pandemic and Healthcare Technology Solutions 251 269 .

Gerco den Hartog, Eric R A Vos, Lotus L van den Hoogen, Michiel van Boven, Rutger M Schepp, Gaby Smits, Jeffrey van Vliet, Linde Woudstra, Alienke J Wijmenga-Monsuur, Cheyenne C E van Hagen, Elisabeth A M Sanders, Hester E de Melker, Fiona R M van der Klis & Robert S van Binnendijk. (2021) Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study. Clinical Infectious Diseases 73:12, pages 2155-2162.
Crossref

Nina Butkovich, Enya Li, Aaron Ramirez, Amanda M. Burkhardt & Szu‐Wen Wang. (2020) Advancements in protein nanoparticle vaccine platforms to combat infectious disease. WIREs Nanomedicine and Nanobiotechnology 13:3.
Crossref

Carlota Dobaño, Marta Vidal, Rebeca Santano, Alfons Jiménez, Jordi Chi, Diana Barrios, Gemma Ruiz-Olalla, Natalia Rodrigo Melero, Carlo Carolis, Daniel Parras, Pau Serra, Paula Martínez de Aguirre, Francisco Carmona-Torre, Gabriel Reina, Pere Santamaria, Alfredo Mayor, Alberto L. García-Basteiro, Luis Izquierdo, Ruth Aguilar & Gemma Moncunill. (2021) Highly Sensitive and Specific Multiplex Antibody Assays To Quantify Immunoglobulins M, A, and G against SARS-CoV-2 Antigens. Journal of Clinical Microbiology 59:2.
Crossref

Gerco den Hartog, Rutger M Schepp, Marjan Kuijer, Corine GeurtsvanKessel, Josine van Beek, Nynke Rots, Marion P G Koopmans, Fiona R M van der Klis & Robert S van Binnendijk. (2020) SARS-CoV-2–Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence. The Journal of Infectious Diseases 222:9, pages 1452-1461.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Immune surveillance for vaccine-preventable diseases

Articles from other publishers (11)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Immune surveillance for vaccine-preventable diseases

Citations (11)

Articles from other publishers (11)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date